The apixaban market grows at a CAGR of 5.70% while going from USD 1,765.8 million in 2022 up to USD 2,908.17 million in the forecast period by the year 2030.
The apixaban market grows at a CAGR of 5.70% while going from USD 1,765.8 million in 2022 up to USD 2,908.17 million in the forecast period by the year 2030.
The apixaban market grows at a CAGR of 5.70% while going from USD 1,765.8 million in 2022 up to USD 2,908.17 million in the forecast period by the year 2030.
The apixaban market grows at a CAGR of 5.70% while going from USD 1,765.8 million in 2022 up to USD 2,908.17 million in the forecast period by the year 2030.
The apixaban market grows at a CAGR of 5.70% while going from USD 1,765.8 million in 2022 up to USD 2,908.17 million in the forecast period by the year 2030.